Skip to main content

Drug Screening Market to Reach Market Valuation of USD 35.18 Billion by 2031 | SkyQuest Technology

Global Drug Screening Market size was valued at USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031). Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Drug Screening Market will reach a value of USD 35.18 Billion by 2031, with a CAGR of 16.5% during the forecast period (2024-2031). Drug screening market is speedily progressing with focus on the analysis or testing for the presence of substances and drugs in individuals. It comprises testing methods like saliva, blood, urine and hair and applications like forensic examinations, workplace testing, and clinical diagnostics. The drug screening market is propelled by the growing awareness of substance abuse, workplace safety needs and strict regulations, and improvements in testing...

Continue reading

Form 8.3 – [KEYWORDS STUDIOS PLC – 26 09 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ECKOH PLC – 26 09 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Uniti Group Inc. Announces Pricing of Windstream Refinancing Transactions

Windstream Will Amend Credit Agreement to Allow Collapse of Dual Debt Silos Upon Closing of Planned Merger LITTLE ROCK, Ark., Sept. 26, 2024 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) today announced the pricing of $800 million aggregate principal amount of new 8.250% Senior First Lien Notes due 2031 (the “New Windstream Notes”) by Windstream Services, LLC and Windstream Escrow Finance Corp. (collectively, the “Windstream Co-Issuers”), each a subsidiary of Windstream Holdings II, LLC (“Windstream”). The indenture governing the New Windstream Notes will contain provisions that allow for the collapse of Uniti’s and Windstream’s debt silos (the “Post-Closing Reorganization”) upon the closing of the planned merger between Uniti and Windstream. The offering of the New Windstream Notes is expected to close on October...

Continue reading

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction remains subject to TauRx board approval. Following the completion of the transaction Dundee will continue to hold 1,007,008 TauRx shares. ABOUT DUNDEE CORPORATION Dundee Corporation is a public Canadian independent holding company, listed on the Toronto Stock Exchange under the symbol “DC.A”. Through its operating subsidiaries, Dundee Corporation is an active investor focused on delivering long-term, sustainable value as a trusted partner in the mining sector with more than 30 years of experience making accretive...

Continue reading

Foxx Development Closes Business Combination with Acri Capital Acquisition Corporation and Will Begin Trading on Nasdaq

Business Combination between Foxx Development Inc. and Acri Capital Acquisition Corporation closed on September 26, 2024 Trading of common stock and warrants of the new public company, Foxx Development Holdings Inc., commence on Nasdaq on September 27, 2024 under the ticker symbols “FOXX” and “FOXXW”Austin, TX, Sept. 26, 2024 (GLOBE NEWSWIRE) — Foxx Development Holdings Inc. (Nasdaq: FOXX), a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients, today announced the successful closing of the previously announced business combination (“the Business Combination”) between Foxx Development Inc. (“Foxx”) and Acri Capital Acquisition Corporation (“Acri”), a publicly traded special purpose acquisition company. Acri stockholders approved...

Continue reading

Better Choice Company to Present at the 2024 ThinkEquity Conference and Provides Detail on Sales in China and the Acquisition of SRx Health

Sustained Sales Momentum in China in Q3 Following 37% Sequential Growth in Q2 Acquisition of SRx Health Remains On-Track TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it will present at the ThinkEquity Conference on October 30th, 2024 at the Mandarin Oriental Hotel in New York City. During the conference, management will provide updates on its international sales performance and the ongoing acquisition of SRx Health. Key Highlights will Include:China Sales Growth: The Company continues to experience sales growth internationally, with sales from China increasing 37% sequentially for the second quarter of 2024 as compared to the first quarter of 2024. International sales account for approximately 28% of Better...

Continue reading

Form 8.3 – AXA INVESTMENT MANAGERS: Segro plc Amend

FORM 8.3 – Amendment to 2. (a) (1) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SEGRO plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For...

Continue reading

Digital Marketing Agency, New Engen, Acquires Creative-Led Performance Marketing Agency, Donut Digital

Deal strengthens New Engen’s creative foundation, establishing a full-service content studio to deliver high-impact, social-first content for brands across all stages of the customer journey SEATTLE, Sept. 26, 2024 (GLOBE NEWSWIRE) — New Engen, a leading digital marketing agency, today announced the acquisition of Donut Digital, a creative-led performance marketing agency based in Manhattan Beach, California. Founded in 2021, Donut Digital has established a reputation as one of the most innovative and fastest growing performance agencies through a highly differentiated creative-centric approach and efficient in-house production capabilities. Donut Digital’s acquisition will allow New Engen to create a full-service content studio, meeting client needs across all stages of the customer journey, from short form video and user generated...

Continue reading

Gevo Acquires CultivateAI for its Verity Business Unit

Accelerates revenue, capability, and growth of Verity ENGLEWOOD, Colo., Sept. 26, 2024 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) has acquired Cultivate Agricultural Intelligence, LLC (“CultivateAI”) for $6 million in cash, with the opportunity for the sellers to receive additional earn-out payments. Gevo will fold CultivateAI into its wholly owned Verity subsidiary to accelerate Verity’s business development and growth. CultivateAI is a proven business with expected 2024 revenue of $1.7 million and corresponding positive cash flow. CultivateAI provides agricultural data to clients through a software as a service (“SaaS”) platform. Gevo expects to combine CultivateAI’s digital agriculture data and analytics platform with Verity’s carbon accounting and tracking solutions to provide the highest quality data-driven solutions for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.